Aldeyra Therapeutics Schedules Webcast & Conference Call to Announce Top-Line Results from the SOLACE Trial in Noninfectious ...
June 24 2019 - 4:30PM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced it will hold a webcast
and conference call on Tuesday, June 25, 2019 at 8:00 a.m. Eastern
Time to provide top-line results from the SOLACE trial of topical
ocular reproxalap in patients with noninfectious anterior
uveitis.
The dial-in numbers are (866) 211-4098 for domestic callers and
(647) 689-6613 for international callers. The Conference ID is
8856138. A live, listen-only audio webcast of the conference call
can be accessed on the investor relations page of Aldeyra's
corporate website at ir.aldeyra.com. After the live webcast, the
event will remain archived on the Aldeyra Therapeutics website for
thirty days.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases. Aldeyra's lead product candidate,
reproxalap, is a first-in-class treatment in late-stage development
for dry eye disease, allergic conjunctivitis, noninfectious
anterior uveitis, and Sj�gren-Larsson Syndrome. The company is also
developing other product candidates for proliferative
vitreoretinopathy and other retinal diseases, post-transplant
lymphoproliferative disease, autoimmune disease, metabolic disease,
and cancer. None of Aldeyra's product candidates have been approved
for sale in the U.S. or elsewhere.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190624005667/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com
Investor Contact: Chris Brinzey Westwicke, an ICR Company
Tel: 339-970-2843 Chris.brinzey@westwicke.com
Media Contact: Sean Leous Westwicke, an ICR Company Tel:
646-677-1839 Sean.leous@icrinc.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
